Literature DB >> 15166394

In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI.

Rikin A Trivedi1, Jean-Marie U-King-Im, Martin J Graves, Justin J Cross, Jo Horsley, Martin J Goddard, Jeremy N Skepper, George Quartey, Elizabeth Warburton, Ilse Joubert, Liqun Wang, Peter J Kirkpatrick, John Brown, Jonathan H Gillard.   

Abstract

UNLABELLED: Background- It has been suggested that inflammatory cells within vulnerable plaques may be visualized by superparamagnetic iron oxide particle-enhanced MRI. The purpose of this study was to determine the time course for macrophage visualization with in vivo contrast-enhanced MRI using an ultrasmall superparamagnetic iron oxide (USPIO) agent in symptomatic human carotid disease.
METHODS: Eight patients scheduled for carotid endarterectomy underwent multisequence MRI of the carotid bifurcation before and 24, 36, 48, and 72 hours after Sinerem (2.6 mg/kg) infusion.
RESULTS: USPIO particles accumulated in macrophages in 7 of 8 patients given Sinerem. Areas of signal intensity reduction, corresponding to USPIO/macrophage-positive histological sections, were visualized in all 7 of these patients, optimally between 24 and 36 hours, decreasing after 48 hours, but still evident up to 96 hours after infusion.
CONCLUSIONS: USPIO-enhanced MRI of carotid atheroma can be used to identify macrophages in vivo. The temporal change in the resultant signal intensity reduction on MRI suggests an optimal time window for the detection of macrophages on postinfusion imaging.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166394     DOI: 10.1161/01.STR.0000131268.50418.b7

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  85 in total

Review 1.  Targeted probes for cardiovascular MRI.

Authors:  Ritika Uppal; Peter Caravan
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

2.  In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes.

Authors:  Karen C Briley-Saebo; Tuyen Hoang Nguyen; Alexander M Saeboe; Young-Seok Cho; Sung Kee Ryu; Eugenia R Volkova; Eugenia Volkava; Stephen Dickson; Gregor Leibundgut; Philipp Wiesner; Philipp Weisner; Simone Green; Florence Casanada; Yury I Miller; Walter Shaw; Joseph L Witztum; Zahi A Fayad; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2012-02-07       Impact factor: 24.094

3.  A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis.

Authors:  Jason R McCarthy; Ethan Korngold; Ralph Weissleder; Farouc A Jaffer
Journal:  Small       Date:  2010-09-20       Impact factor: 13.281

Review 4.  Targeting the vulnerable plaque: the evolving role of nuclear imaging.

Authors:  John R Davies; James F Rudd; Tim D Fryer; Peter L Weissberg
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

Review 5.  Imaging the vertebral artery.

Authors:  Keng Yeow Tay; Jean Marie U-King-Im; Rikin A Trivedi; Nicholas J Higgins; Justin J Cross; John R Davies; Peter L Weissberg; Nagui M Antoun; Jonathan H Gillard
Journal:  Eur Radiol       Date:  2005-01-27       Impact factor: 5.315

Review 6.  Cardiovascular molecular imaging: focus on clinical translation.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circulation       Date:  2011-02-01       Impact factor: 29.690

Review 7.  Molecular imaging of cerebrovascular lesions.

Authors:  Nohra Chalouhi; Pascal Jabbour; Vincent Magnotta; David Hasan
Journal:  Transl Stroke Res       Date:  2013-10-23       Impact factor: 6.829

8.  Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultra small superparamagnetic iron oxide enhanced magnetic resonance study.

Authors:  Tjun Y Tang; Simon P S Howarth; Sam R Miller; Martin J Graves; Jean-Marie U-King-Im; Rikin A Trivedi; Zhi Yong Li; Stewart R Walsh; Andrew P Brown; Peter J Kirkpatrick; Michael E Gaunt; Jonathan H Gillard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-06-19       Impact factor: 10.154

9.  Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.

Authors:  Yi-Xiang J Wang
Journal:  Quant Imaging Med Surg       Date:  2011-12

10.  Molecular MRI of Atherosclerotic Plaque With Targeted Contrast Agents.

Authors:  David E Sosnovik; Peter Caravan
Journal:  Curr Cardiovasc Imaging Rep       Date:  2009-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.